Literature DB >> 10898035

CT blood pool enhancement in primates with lopromide-carrying liposomes containing soy phosphatidyl glycerol.

U P Schmiedl1, W Krause, J Leike, A Sachse.   

Abstract

RATIONALE AND
OBJECTIVES: The purpose of this study was to determine the feasibility of using iodinated liposomes as blood pool agents for computed tomography (CT) in nonhuman primates.
MATERIALS AND METHODS: Five normal adult baboons (15-21 kg) were anesthetized and intravenously injected with iopromide containing soy phosphatidyl glycerol liposomes with a diameter of 195 nm. Each animal received a dose of 300 mg total iodine per kilogram (46% encapsulation).
RESULTS: The animals tolerated the injections well, experiencing no measurable electrocardiographic changes, and recovered uneventfully from anesthesia. Sequential helical CT scans of the baboons from the base of the skull to the symphysis pubis acquired up to 40 minutes after injection showed persistent blood pool enhancement. Maximum mean enhancement of major vascular structures was 106 HU at 1 minute after contrast medium injection. Mean blood pool enhancement was 76, 72, and 67 HU at 10, 20, and 40 minutes after injection, respectively. Liver and spleen were enhanced by 40 and 41 HU, respectively, 40 minutes after injection. No significant enhancement was measured in the brain and pancreas.
CONCLUSION: Soy phosphatidyl glycerol with iopromide liposomes produces prolonged vascular enhancement and has potential as a blood pool CT contrast agent in primates.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10898035     DOI: 10.1016/S1076-6332(99)80402-4

Source DB:  PubMed          Journal:  Acad Radiol        ISSN: 1076-6332            Impact factor:   3.173


  5 in total

Review 1.  Design and pharmacokinetical aspects for the use of inorganic nanoparticles in radiomedicine.

Authors:  Victor Puntes
Journal:  Br J Radiol       Date:  2015-10-23       Impact factor: 3.039

Review 2.  Nanotechnology for computed tomography: a real potential recently disclosed.

Authors:  Nicolas Anton; Thierry F Vandamme
Journal:  Pharm Res       Date:  2013-07-30       Impact factor: 4.200

Review 3.  The use of hyperpolarized carbon-13 magnetic resonance for molecular imaging.

Authors:  Sarmad Siddiqui; Stephen Kadlecek; Mehrdad Pourfathi; Yi Xin; William Mannherz; Hooman Hamedani; Nicholas Drachman; Kai Ruppert; Justin Clapp; Rahim Rizi
Journal:  Adv Drug Deliv Rev       Date:  2016-09-04       Impact factor: 15.470

4.  AuNP-DG: deoxyglucose-labeled gold nanoparticles as X-ray computed tomography contrast agents for cancer imaging.

Authors:  Bulent Aydogan; Ji Li; Tijana Rajh; Ahmed Chaudhary; Steven J Chmura; Charles Pelizzari; Christian Wietholt; Metin Kurtoglu; Peter Redmond
Journal:  Mol Imaging Biol       Date:  2010-10       Impact factor: 3.488

5.  Imaging of pulmonary embolism and t-PA therapy effects using MDCT and liposomal iohexol blood pool agent: preliminary results in a rabbit model.

Authors:  Stephen J Burke; Ananth Annapragada; Eric A Hoffman; Emmanuel Chen; Ketan B Ghaghada; Jered Sieren; Edwin J R van Beek
Journal:  Acad Radiol       Date:  2007-03       Impact factor: 3.173

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.